Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors

Detalles Bibliográficos
Autores principales: Minami, Y, Abe, A, Minami, M, Kitamura, K, Hiraga, J, Mizuno, S, Ymamoto, K, Sawa, M, Inagaki, Y, Miyamura, K, Naoe, T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437405/
https://www.ncbi.nlm.nih.gov/pubmed/22425893
http://dx.doi.org/10.1038/leu.2012.73
_version_ 1782242778825097216
author Minami, Y
Abe, A
Minami, M
Kitamura, K
Hiraga, J
Mizuno, S
Ymamoto, K
Sawa, M
Inagaki, Y
Miyamura, K
Naoe, T
author_facet Minami, Y
Abe, A
Minami, M
Kitamura, K
Hiraga, J
Mizuno, S
Ymamoto, K
Sawa, M
Inagaki, Y
Miyamura, K
Naoe, T
author_sort Minami, Y
collection PubMed
description
format Online
Article
Text
id pubmed-3437405
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-34374052012-09-10 Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors Minami, Y Abe, A Minami, M Kitamura, K Hiraga, J Mizuno, S Ymamoto, K Sawa, M Inagaki, Y Miyamura, K Naoe, T Leukemia Letter to the Editor Nature Publishing Group 2012-09 2012-04-10 /pmc/articles/PMC3437405/ /pubmed/22425893 http://dx.doi.org/10.1038/leu.2012.73 Text en Copyright © 2012 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/
spellingShingle Letter to the Editor
Minami, Y
Abe, A
Minami, M
Kitamura, K
Hiraga, J
Mizuno, S
Ymamoto, K
Sawa, M
Inagaki, Y
Miyamura, K
Naoe, T
Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
title Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
title_full Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
title_fullStr Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
title_full_unstemmed Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
title_short Retention of CD34(+) CML stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation BCR–ABL inhibitors
title_sort retention of cd34(+) cml stem/progenitor cells during imatinib treatment and rapid decline after treatment with second-generation bcr–abl inhibitors
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437405/
https://www.ncbi.nlm.nih.gov/pubmed/22425893
http://dx.doi.org/10.1038/leu.2012.73
work_keys_str_mv AT minamiy retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT abea retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT minamim retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT kitamurak retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT hiragaj retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT mizunos retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT ymamotok retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT sawam retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT inagakiy retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT miyamurak retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors
AT naoet retentionofcd34cmlstemprogenitorcellsduringimatinibtreatmentandrapiddeclineaftertreatmentwithsecondgenerationbcrablinhibitors

Ejemplares similares